Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
600195.SS
HOLDREMOVEChina Animal Husbandry Industry Co., Ltd. · Healthcare · China · $996M · Avg Vol: $7M/d
China Animal Husbandry lacks strong global moats and clear thematic alignment with our high-conviction macro themes.
COMPANY DESCRIPTION
China Animal Husbandry Industry is a leading state-owned enterprise in China's animal health sector, manufacturing veterinary vaccines, pharmaceuticals, and feed additives. The company holds a dominant market share in compulsory national vaccines (such as Foot-and-Mouth Disease), backed by strong R&D and regulatory approvals. It plays a critical role in safeguarding China's livestock industry and food security.
FINANCIAL SUMMARY
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 871M | 799M | 889M | 917M | 1.7% |
| EPS | 0.08 | 0.06 | 0.01 | 0.02 | -32.3% |
| Shares | 1.0B | 1.0B | 1.0B | 1.0B | 0.0% |
| Debt | 48M | 202M | 151M | 155M | 48.0% |
| Equity | 783M | 816M | 814M | 838M | 2.3% |
| Op CF | -33M | 55M | 62M | 171M | 76.3% |
| Inv CF | -25M | -77M | -63M | -47M | — |
| Fin CF | 8M | 112M | -73M | 5M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600195.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 600195.SS | China Animal Husbandry Industry Co., Ltd.(you) | $996M | 64 | HOLD |
| 000597.SZ | Northeast Pharmaceutical Group Co., Ltd. | $983M | 64 | HOLD |
| 600557.SS | Jiangsu Kanion Pharmaceutical Co.,Ltd. | $1.1B | 65 | HOLD |
| 2186.HK | Luye Pharma Group Ltd. | $1.1B | 61 | HOLD |
| 002550.SZ | Changzhou Qianhong Biopharma CO.,LTD | $1.2B | 66 | BUY |
| 603439.SS | Guizhou Sanli Pharmaceutical Co.,Ltd | $984M | 70 | BUY |
| 688566.SS | Jiangsu Jibeier Pharmaceutical Co., Ltd. | $741M | 65 | BUY |
| 300039.SZ | Shanghai Kaibao Pharmaceutical CO.,Ltd | $822M | 68 | BUY |
| 300725.SZ | PharmaBlock Sciences (Nanjing), Inc. | $1.2B | 60 | HOLD |
| 601089.SS | Beijing Foyou Pharma CO.,LTD | $1.3B | 61 | HOLD |
Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%